Robert Lanza
Latest News
-
Stem Cell Hype Has Yet To Breed Profits
— May 22 2012 9:55 AM from Seeking Alpha -
ACT Announces Data and Safety Monitoring Board (DSMB) Approval to Increase RPE Dosage for Stargardt’s Disease Patients in U.S. Trial
— Apr 24 2012 12:40 PM from Business Wire -
QualityStocks News - Advance Cell Technology Completes Treatment of Third Dry AMD Patient in Phase I/II Clinical Trial
— Apr 21 2012 4:41 PM from Emediawire.com






